Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression

Br J Haematol. 2020 Jun;189(6):e222-e224. doi: 10.1111/bjh.16781. Epub 2020 May 19.
No abstract available

Keywords: AML; COVID-19; SARS-CoV-2; childhood cancer; coronavirus disease 2019; immunosuppression.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents* / administration & dosage
  • Antineoplastic Agents* / adverse effects
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections* / chemically induced
  • Coronavirus Infections* / diagnostic imaging
  • Coronavirus Infections* / drug therapy
  • Female
  • Humans
  • Hydroxychloroquine / administration & dosage*
  • Immune Tolerance / drug effects*
  • Infant
  • Leukemia, Myeloid, Acute* / diagnostic imaging
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / virology
  • Lopinavir / administration & dosage*
  • Pandemics*
  • Pneumonia, Viral* / chemically induced
  • Pneumonia, Viral* / diagnostic imaging
  • Pneumonia, Viral* / drug therapy
  • Ritonavir / administration & dosage*
  • SARS-CoV-2

Substances

  • Antineoplastic Agents
  • Lopinavir
  • Hydroxychloroquine
  • Ritonavir